SAGE Therapeutics Announces Results from Successful Exploratory Trial in Essential Tremor

By: via Benzinga
SAGE Therapeutics (NASDAQ: SAGE) today announced results from a successful exploratory clinical trial of SAGE-547 to evaluate the GABAA ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.